Free Trial

Quoin Pharmaceuticals (QNRX) Competitors

Quoin Pharmaceuticals logo
$8.31 -0.25 (-2.92%)
Closing price 07/25/2025 03:56 PM Eastern
Extended Trading
$8.18 -0.13 (-1.55%)
As of 07/25/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QNRX vs. NRXS, PSTV, PETV, NXGL, IINN, BDMD, XAIR, INBS, MHUA, and DHAI

Should you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include NeurAxis (NRXS), Plus Therapeutics (PSTV), PetVivo (PETV), NexGel (NXGL), Inspira Technologies OXY B.H.N. (IINN), Baird Medical Investment (BDMD), Beyond Air (XAIR), Intelligent Bio Solutions (INBS), Meihua International Medical Technologies (MHUA), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry.

Quoin Pharmaceuticals vs. Its Competitors

NeurAxis (NASDAQ:NRXS) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

NeurAxis currently has a consensus price target of $7.00, suggesting a potential upside of 152.71%. Given NeurAxis' stronger consensus rating and higher possible upside, equities research analysts plainly believe NeurAxis is more favorable than Quoin Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Quoin Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Quoin Pharmaceuticals had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Quoin Pharmaceuticals and 0 mentions for NeurAxis. Quoin Pharmaceuticals' average media sentiment score of 1.87 beat NeurAxis' score of 0.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
NeurAxis Neutral
Quoin Pharmaceuticals Very Positive

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 26.4% of NeurAxis shares are held by company insiders. Comparatively, 3.7% of Quoin Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Quoin Pharmaceuticals has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxis-492.76% N/A -641.25%
Quoin Pharmaceuticals N/A -148.97%-77.23%

Quoin Pharmaceuticals has lower revenue, but higher earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$2.93M6.81-$14.63M-$1.19-2.33
Quoin PharmaceuticalsN/AN/A-$8.96M-$48.81-0.17

NeurAxis has a beta of 3.09, meaning that its share price is 209% more volatile than the S&P 500. Comparatively, Quoin Pharmaceuticals has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

Summary

NeurAxis beats Quoin Pharmaceuticals on 9 of the 15 factors compared between the two stocks.

Get Quoin Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QNRX vs. The Competition

MetricQuoin PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$5.03M$2.50B$5.70B$9.50B
Dividend YieldN/A1.75%4.69%4.01%
P/E Ratio-0.179.0528.1020.06
Price / SalesN/A592.38428.7189.11
Price / CashN/A165.2136.2258.56
Price / Book0.235.168.665.87
Net Income-$8.96M$30.99M$3.25B$258.55M
7 Day Performance-2.00%7.74%4.22%3.73%
1 Month Performance-14.59%16.27%10.51%11.75%
1 Year Performance-61.00%-1.88%34.40%18.02%

Quoin Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QNRX
Quoin Pharmaceuticals
1.6621 of 5 stars
$8.31
-2.9%
N/A-62.7%$5.03MN/A-0.174
NRXS
NeurAxis
2.6782 of 5 stars
$2.73
flat
$7.00
+156.4%
-11.2%$19.70M$2.93M-1.4819
PSTV
Plus Therapeutics
1.6243 of 5 stars
$0.39
+0.5%
$10.83
+2,706.6%
-70.6%$19.69MN/A-0.1320
PETV
PetVivo
N/A$0.80
-3.7%
N/A+23.1%$19.54M$1.05M-1.7820
NXGL
NexGel
0.8513 of 5 stars
$2.45
+2.5%
N/A-11.4%$18.59M$8.69M-5.4010
IINN
Inspira Technologies OXY B.H.N.
2.0045 of 5 stars
$1.38
+5.8%
$2.00
+45.5%
+33.0%$17.29MN/A0.0020
BDMD
Baird Medical Investment
N/A$2.29
-25.2%
N/AN/A$15.07MN/A0.00N/A
XAIR
Beyond Air
4.4788 of 5 stars
$3.41
+2.6%
$23.67
+595.1%
-74.5%$14.71M$3.70M-0.2270Analyst Upgrade
High Trading Volume
INBS
Intelligent Bio Solutions
1.0351 of 5 stars
$2.08
+2.5%
N/A+14.2%$14.37M$3.11M0.0010Positive News
Gap Up
MHUA
Meihua International Medical Technologies
0.9563 of 5 stars
$0.41
-4.6%
N/A-62.7%$13.14M$96.90M0.00620
DHAI
DIH Holding US
0.2856 of 5 stars
$0.27
-8.4%
N/A-91.4%$12.83M$64.47M-0.90N/AGap Down

Related Companies and Tools


This page (NASDAQ:QNRX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners